Free Trial

Xencor (XNCR) Financials

Xencor logo
$7.57 -0.12 (-1.56%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$7.38 -0.19 (-2.50%)
As of 05/23/2025 05:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Xencor

Annual Income Statements for Xencor

This table shows Xencor's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Net Income / (Loss) Attributable to Common Shareholders
-233 -133 -55
Consolidated Net Income / (Loss)
-237 -133 -55
Net Income / (Loss) Continuing Operations
-237 -133 -55
Total Pre-Tax Income
-235 -120 -55
Total Operating Income
-178 -132 -82
Total Gross Profit
110 175 165
Total Revenue
110 175 165
Operating Revenue
110 175 165
Total Cost of Revenue
0.00 0.00 0.00
Total Operating Expenses
289 307 247
Selling, General & Admin Expense
61 53 47
Research & Development Expense
228 254 200
Total Other Income / (Expense), net
-57 13 28
Interest Expense
4.71 -13 -4.82
Other Income / (Expense), net
-52 -0.43 23
Income Tax Expense
1.62 14 0.67
Net Income / (Loss) Attributable to Noncontrolling Interest
-3.92 -0.16 0.00
Basic Earnings per Share
($3.58) ($2.20) ($0.93)
Weighted Average Basic Shares Outstanding
65.04M 60.50M 59.65M
Diluted Earnings per Share
($3.58) ($2.20) ($0.93)
Weighted Average Diluted Shares Outstanding
65.04M 60.50M 59.65M
Weighted Average Basic & Diluted Shares Outstanding
70.46M 61.12M 60.03M

Quarterly Income Statements for Xencor

This table shows Xencor's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
-46 -46 -67 -73 -26 -24 -22 -61 -3.68 -34
Consolidated Net Income / (Loss)
-46 -47 -69 -74 -26 -24 -22 -61 -12 -33
Net Income / (Loss) Continuing Operations
-46 -47 -69 -74 -26 -24 -22 -61 -12 -33
Total Pre-Tax Income
-45 -47 -69 -74 -13 -24 -22 -61 -12 -32
Total Operating Income
-13 -55 -55 -55 -27 -18 -26 -61 -43 -38
Total Gross Profit
53 18 24 16 51 59 46 19 22 27
Total Revenue
53 18 24 16 51 59 46 19 22 27
Operating Revenue
53 18 24 16 51 59 46 19 22 27
Total Operating Expenses
66 73 79 71 78 77 72 80 64 66
Selling, General & Admin Expense
15 15 18 14 15 12 11 14 13 12
Research & Development Expense
51 58 62 57 63 65 60 66 51 53
Total Other Income / (Expense), net
-31 7.76 -13 -19 15 -6.00 4.04 -0.02 30 6.68
Interest Expense
-23 9.03 9.28 9.68 -13 0.01 0.01 0.01 -2.07 -1.38
Other Income / (Expense), net
-31 9.24 -12 -18 13 -11 0.28 -2.91 28 5.30
Net Income / (Loss) Attributable to Noncontrolling Interest
-0.65 -1.15 -1.45 -0.68 -0.16 0.00 0.00 0.00 - -
Basic Earnings per Share
($0.57) ($0.72) ($1.09) ($1.20) ($0.41) ($0.40) ($0.37) ($1.02) ($0.21) ($0.55)
Weighted Average Basic Shares Outstanding
65.04M 64.02M 61.68M 61.21M 60.50M 60.62M 59.81M 59.77M 59.65M 59.72M
Diluted Earnings per Share
($0.57) ($0.72) ($1.09) ($1.20) ($0.41) ($0.40) ($0.37) ($1.02) ($0.20) ($0.55)
Weighted Average Diluted Shares Outstanding
65.04M 64.02M 61.68M 61.21M 60.50M 60.62M 59.81M 59.77M 59.65M 59.72M
Weighted Average Basic & Diluted Shares Outstanding
70.46M 69.98M 61.83M 61.66M 61.12M 60.88M 60.61M 60.39M 60.03M 59.92M

Annual Cash Flow Statements for Xencor

This table details how cash moves in and out of Xencor's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Net Change in Cash & Equivalents
-13 0.23 -90
Net Cash From Operating Activities
-202 -78 24
Net Cash From Continuing Operating Activities
-202 -78 24
Net Income / (Loss) Continuing Operations
-237 -133 -55
Consolidated Net Income / (Loss)
-237 -133 -55
Depreciation Expense
12 11 8.80
Amortization Expense
-16 -14 0.13
Non-Cash Adjustments To Reconcile Net Income
44 60 82
Changes in Operating Assets and Liabilities, net
-5.83 -2.92 -11
Net Cash From Investing Activities
-7.87 -111 -120
Net Cash From Continuing Investing Activities
-7.87 -111 -120
Purchase of Property, Plant & Equipment
-6.10 -18 -38
Acquisitions
-3.42 -2.80 -4.91
Purchase of Investments
-595 -783 -388
Sale of Property, Plant & Equipment
0.00 0.00 0.00
Sale and/or Maturity of Investments
597 693 307
Other Investing Activities, net
0.00 0.00 5.00
Net Cash From Financing Activities
197 189 5.70
Net Cash From Continuing Financing Activities
197 189 5.70
Repurchase of Common Equity
-12 0.00 0.00
Issuance of Common Equity
209 5.89 5.70
Other Financing Activities, net
0.00 183 0.00
Cash Interest Paid
0.03 0.02 0.01
Cash Income Taxes Paid
6.10 0.00 0.70

Quarterly Cash Flow Statements for Xencor

This table details how cash moves in and out of Xencor's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
12 -1.74 -0.26 -23 1.06 18 -38 18 1.29 3.24
Net Cash From Operating Activities
-50 -32 -69 -57 18 -27 -38 -31 -24 -1.17
Net Cash From Continuing Operating Activities
-50 -32 -69 -57 18 -27 -38 -31 -24 -1.17
Net Income / (Loss) Continuing Operations
-46 -54 -74 -74 -26 -24 -22 -61 -12 -33
Consolidated Net Income / (Loss)
-46 -54 -74 -74 -26 -24 -22 -61 -12 -33
Depreciation Expense
2.99 3.05 3.02 3.04 3.23 3.14 2.89 2.25 2.16 2.24
Amortization Expense
-2.54 -3.47 -4.44 -5.60 -5.42 -3.87 -2.68 -1.66 -0.78 -0.06
Non-Cash Adjustments To Reconcile Net Income
3.93 -9.19 4.50 26 41 -11 3.81 27 -3.02 30
Changes in Operating Assets and Liabilities, net
-8.03 32 2.15 -6.42 5.96 8.72 -20 2.65 -11 -1.07
Net Cash From Investing Activities
57 -163 66 32 -203 45 -1.41 48 25 3.13
Net Cash From Continuing Investing Activities
57 -163 66 32 -203 45 -1.41 48 25 3.13
Purchase of Property, Plant & Equipment
-1.66 -1.28 -3.03 -0.13 -0.98 -2.83 -3.85 -11 -9.97 -14
Acquisitions
-1.02 -0.85 -0.62 -0.93 -0.73 -0.59 -1.08 -0.41 -0.93 -0.78
Purchase of Investments
-54 -282 -123 -137 -338 -168 -181 -95 -71 -111
Sale and/or Maturity of Investments
114 120 192 170 137 217 185 155 101 129
Net Cash From Financing Activities
4.43 193 2.67 1.79 186 0.36 1.92 0.92 1.17 1.29
Net Cash From Continuing Financing Activities
4.43 193 2.67 1.79 186 0.36 1.92 0.92 1.17 1.29
Issuance of Common Equity
4.43 202 1.07 1.79 2.69 0.36 1.92 0.92 1.17 1.29
Cash Interest Paid
0.00 0.01 0.01 0.01 0.00 0.01 0.01 0.01 - 0.00

Annual Balance Sheets for Xencor

This table presents Xencor's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Total Assets
952 965 846
Total Current Assets
578 636 675
Cash & Equivalents
41 54 54
Short-Term Investments
457 540 569
Accounts Receivable
61 24 29
Prepaid Expenses
19 18 23
Plant, Property, & Equipment, net
60 66 59
Total Noncurrent Assets
315 263 112
Long-Term Investments
257 210 3.83
Intangible Assets
18 19 19
Other Noncurrent Operating Assets
39 35 89
Total Liabilities & Shareholders' Equity
952 965 846
Total Liabilities
278 303 119
Total Current Liabilities
87 74 64
Short-Term Debt
48 28 0.00
Accounts Payable
17 14 10
Accrued Expenses
19 24 19
Current Deferred & Payable Income Tax Liabilities
0.00 5.29 0.00
Other Current Liabilities
3.01 3.44 4.71
Total Noncurrent Liabilities
190 229 55
Long-Term Debt
115 162 0.00
Other Noncurrent Operating Liabilities
75 67 55
Commitments & Contingencies
0.00 0.00 0.00
Total Equity & Noncontrolling Interests
674 662 727
Total Preferred & Common Equity
678 662 727
Preferred Stock
0.00 0.00 0.00
Total Common Equity
678 662 727
Common Stock
1,382 1,132 1,073
Retained Earnings
-704 -471 -338
Accumulated Other Comprehensive Income / (Loss)
-0.66 1.29 -6.95
Noncontrolling Interest
-3.59 0.34 0.00

Quarterly Balance Sheets for Xencor

This table presents Xencor's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets
1,000 841 897 778 778 803 835
Total Current Assets
590 569 575 571 594 630 668
Cash & Equivalents
29 31 31 53 35 72 53
Short-Term Investments
514 478 505 442 517 516 548
Accounts Receivable
26 36 22 55 20 20 45
Prepaid Expenses
21 25 17 22 22 22 23
Plant, Property, & Equipment, net
62 64 64 68 68 67 51
Total Noncurrent Assets
348 208 258 139 117 107 116
Long-Term Investments
290 149 199 85 64 54 42
Intangible Assets
18 19 19 19 19 18 18
Other Noncurrent Operating Assets
40 40 41 36 34 34 51
Total Liabilities & Shareholders' Equity
1,000 841 897 778 778 803 835
Total Liabilities
294 292 297 109 99 120 113
Total Current Liabilities
91 76 71 53 45 65 90
Short-Term Debt
44 39 34 - - - -
Accounts Payable
19 16 16 15 14 15 15
Accrued Expenses
25 20 13 24 18 15 19
Current Deferred Revenue
0.00 - - 9.22 7.87 30 35
Current Deferred & Payable Income Tax Liabilities
0.00 0.00 5.29 - - - 0.39
Other Current Liabilities
2.18 1.26 2.08 4.38 4.23 4.47 21
Total Noncurrent Liabilities
203 216 226 56 55 55 23
Long-Term Debt
128 141 151 - - - -
Other Noncurrent Operating Liabilities
75 75 75 56 55 - 23
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
706 549 600 669 679 684 723
Total Preferred & Common Equity
709 550 600 669 679 684 723
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
709 550 600 669 679 684 723
Common Stock
1,366 1,163 1,145 1,115 1,102 1,086 1,059
Retained Earnings
-658 -612 -545 -445 -421 -399 -326
Accumulated Other Comprehensive Income / (Loss)
1.80 -0.65 -0.15 -0.71 -1.86 -3.63 -9.88
Noncontrolling Interest
-2.94 -1.78 -0.34 - - - -

Annual Metrics And Ratios for Xencor

This table displays calculated financial ratios and metrics derived from Xencor's official financial filings.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Growth Metrics
- - -
Revenue Growth
-36.72% 6.10% -40.18%
EBITDA Growth
-73.54% -167.71% -154.52%
EBIT Growth
-73.37% -123.83% -172.54%
NOPAT Growth
-34.79% -60.49% -231.91%
Net Income Growth
-77.45% -141.56% -166.78%
EPS Growth
-62.73% -136.56% -167.88%
Operating Cash Flow Growth
-159.46% -418.26% 245.29%
Free Cash Flow Firm Growth
-297.79% 32.38% 31.52%
Invested Capital Growth
72.52% -52.17% 1.69%
Revenue Q/Q Growth
19.78% 20.21% -44.58%
EBITDA Q/Q Growth
-4.88% -2.41% -232.10%
EBIT Q/Q Growth
-6.25% 0.30% -312.11%
NOPAT Q/Q Growth
14.64% 10.33% -211.51%
Net Income Q/Q Growth
-16.62% -11.99% -284.42%
EPS Q/Q Growth
-12.23% -10.55% -286.00%
Operating Cash Flow Q/Q Growth
-800.70% 35.35% -77.88%
Free Cash Flow Firm Q/Q Growth
-56.78% 64.27% -338.16%
Invested Capital Q/Q Growth
82.59% -46.44% 24.60%
Profitability Metrics
- - -
Gross Margin
100.00% 100.00% 100.00%
EBITDA Margin
-211.91% -77.27% -30.62%
Operating Margin
-161.47% -75.80% -50.11%
EBIT Margin
-208.35% -76.05% -36.05%
Profit (Net Income) Margin
-214.08% -76.34% -33.53%
Tax Burden Percent
100.69% 111.42% 101.23%
Interest Burden Percent
102.05% 90.09% 91.88%
Effective Tax Rate
0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-190.45% -124.59% -57.86%
ROIC Less NNEP Spread (ROIC-NNEP)
-171.92% -118.04% -58.27%
Return on Net Nonoperating Assets (RNNOA)
155.04% 105.41% 50.31%
Return on Equity (ROE)
-35.41% -19.19% -7.55%
Cash Return on Invested Capital (CROIC)
-243.68% -54.01% -59.54%
Operating Return on Assets (OROA)
-24.02% -14.66% -8.57%
Return on Assets (ROA)
-24.68% -14.72% -7.97%
Return on Common Equity (ROCE)
-35.49% -19.18% -7.55%
Return on Equity Simple (ROE_SIMPLE)
-34.91% -20.14% -7.59%
Net Operating Profit after Tax (NOPAT)
-125 -93 -58
NOPAT Margin
-113.03% -53.06% -35.08%
Net Nonoperating Expense Percent (NNEP)
-18.53% -6.55% 0.40%
Return On Investment Capital (ROIC_SIMPLE)
-14.91% -10.88% -7.94%
Cost of Revenue to Revenue
0.00% 0.00% 0.00%
SG&A Expenses to Revenue
55.40% 30.57% 28.85%
R&D to Revenue
206.06% 145.23% 121.26%
Operating Expenses to Revenue
261.47% 175.80% 150.11%
Earnings before Interest and Taxes (EBIT)
-230 -133 -59
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-234 -135 -50
Valuation Ratios
- - -
Price to Book Value (P/BV)
2.37 1.95 2.14
Price to Tangible Book Value (P/TBV)
2.44 2.01 2.20
Price to Revenue (P/Rev)
14.55 7.40 9.48
Price to Earnings (P/E)
0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
12.21 14.10 9.28
Enterprise Value to Revenue (EV/Rev)
9.17 3.89 5.67
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 38.13
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00
Leverage & Solvency
- - -
Debt to Equity
0.24 0.29 0.00
Long-Term Debt to Equity
0.17 0.24 0.00
Financial Leverage
-0.90 -0.89 -0.86
Leverage Ratio
1.43 1.30 0.95
Compound Leverage Factor
1.46 1.17 0.87
Debt to Total Capital
19.53% 22.25% 0.00%
Short-Term Debt to Total Capital
5.78% 3.25% 0.00%
Long-Term Debt to Total Capital
13.75% 19.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
-0.43% 0.04% 0.00%
Common Equity to Total Capital
80.90% 77.71% 100.00%
Debt to EBITDA
-0.70 -1.40 0.00
Net Debt to EBITDA
2.52 4.55 0.00
Long-Term Debt to EBITDA
-0.49 -1.20 0.00
Debt to NOPAT
-1.31 -2.05 0.00
Net Debt to NOPAT
4.73 6.63 0.00
Long-Term Debt to NOPAT
-0.92 -1.75 0.00
Altman Z-Score
2.37 2.30 8.15
Noncontrolling Interest Sharing Ratio
-0.24% 0.02% 0.00%
Liquidity Ratios
- - -
Current Ratio
6.61 8.60 10.58
Quick Ratio
6.39 8.35 10.21
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
-160 -40 -59
Operating Cash Flow to CapEx
-3,316.19% -422.43% 63.61%
Free Cash Flow to Firm to Interest Expense
-33.90 0.00 0.00
Operating Cash Flow to Interest Expense
-42.90 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
-44.19 0.00 0.00
Efficiency Ratios
- - -
Asset Turnover
0.12 0.19 0.24
Accounts Receivable Turnover
2.61 6.62 3.45
Inventory Turnover
0.00 0.00 0.00
Fixed Asset Turnover
1.75 2.79 3.77
Accounts Payable Turnover
0.00 0.00 0.00
Days Sales Outstanding (DSO)
139.71 55.12 105.77
Days Inventory Outstanding (DIO)
0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00
Cash Conversion Cycle (CCC)
139.71 55.12 105.77
Capital & Investment Metrics
- - -
Invested Capital
83 48 101
Invested Capital Turnover
1.69 2.35 1.65
Increase / (Decrease) in Invested Capital
35 -52 1.68
Enterprise Value (EV)
1,014 679 934
Market Capitalization
1,608 1,292 1,560
Book Value per Share
$9.68 $10.87 $12.14
Tangible Book Value per Share
$9.42 $10.56 $11.83
Total Capital
838 852 727
Total Debt
164 189 0.00
Total Long-Term Debt
115 162 0.00
Net Debt
-591 -614 -627
Capital Expenditures (CapEx)
6.10 18 38
Debt-free, Cash-free Net Working Capital (DFCFNWC)
41 -4.33 -12
Debt-free Net Working Capital (DFNWC)
539 589 611
Net Working Capital (NWC)
490 562 611
Net Nonoperating Expense (NNE)
112 41 -2.55
Net Nonoperating Obligations (NNO)
-591 -614 -627
Total Depreciation and Amortization (D&A)
-3.94 -2.14 8.93
Debt-free, Cash-free Net Working Capital to Revenue
36.96% -2.48% -7.03%
Debt-free Net Working Capital to Revenue
487.47% 337.54% 371.55%
Net Working Capital to Revenue
443.62% 321.67% 371.55%
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
($3.58) $0.00 ($0.93)
Adjusted Weighted Average Basic Shares Outstanding
65.04M 0.00 59.65M
Adjusted Diluted Earnings per Share
($3.58) $0.00 ($0.93)
Adjusted Weighted Average Diluted Shares Outstanding
65.04M 0.00 59.65M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
70.46M 0.00 60.03M
Normalized Net Operating Profit after Tax (NOPAT)
-125 -93 -58
Normalized NOPAT Margin
-113.03% -53.06% -35.08%
Pre Tax Income Margin
-212.61% -68.51% -33.12%
Debt Service Ratios
- - -
EBIT to Interest Expense
-48.85 0.00 0.00
NOPAT to Interest Expense
-26.50 0.00 0.00
EBIT Less CapEx to Interest Expense
-50.14 0.00 0.00
NOPAT Less CapEx to Interest Expense
-27.79 0.00 0.00
Payout Ratios
- - -
Dividend Payout Ratio
0.00% 0.00% 0.00%
Augmented Payout Ratio
-5.11% 0.00% 0.00%

Quarterly Metrics And Ratios for Xencor

This table displays calculated financial ratios and metrics derived from Xencor's official financial filings.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - -
Revenue Growth
3.58% -69.92% -47.48% -15.64% 135.84% 116.73% 50.86% -77.82% -85.97% 38.69%
EBITDA Growth
-167.27% -54.50% -168.81% -19.79% -24.18% 2.79% 20.37% -345.78% -117.44% 17.62%
EBIT Growth
-212.02% -56.92% -161.22% -14.66% 2.71% 11.39% 25.87% -377.47% -119.96% 18.17%
NOPAT Growth
51.82% -202.12% -112.99% 10.01% 35.78% 52.36% 7.15% -260.66% -132.53% 7.15%
Net Income Growth
-75.60% -95.48% -213.30% -21.98% -118.50% 25.92% 35.38% -357.54% -116.48% 18.49%
EPS Growth
-39.02% -80.00% -194.59% -17.65% -105.00% 27.27% 35.09% -361.54% -116.26% 20.29%
Operating Cash Flow Growth
-374.30% -16.40% -80.50% -85.73% 174.37% -2,235.70% -186.29% -626.47% -139.54% 97.01%
Free Cash Flow Firm Growth
-232.35% 126.22% -650.38% 269.65% 205.87% 59.20% 112.84% 95.36% 18.99% 44.83%
Invested Capital Growth
72.52% -49.39% 12.83% -47.59% -52.17% 11.28% -29.68% -28.39% 1.69% 49.76%
Revenue Q/Q Growth
196.66% 4.93% 86.70% -64.20% -13.86% 29.97% 140.07% -12.25% -20.84% -9.53%
EBITDA Q/Q Growth
5.89% 38.62% 12.89% -234.27% 45.60% -17.61% 59.54% -379.74% 57.41% 3.66%
EBIT Q/Q Growth
4.06% 38.01% 11.81% -257.66% 51.75% -13.87% 59.60% -338.27% 56.05% 4.73%
NOPAT Q/Q Growth
76.13% 11.43% 4.30% -62.54% -49.70% 29.72% 57.20% -42.62% -11.06% -36.96%
Net Income Q/Q Growth
2.62% 29.62% -0.11% -284.74% -8.41% -10.54% 63.87% -404.63% 63.24% 3.58%
EPS Q/Q Growth
20.83% 32.71% 1.80% -313.79% -2.50% -8.11% 63.73% -410.00% 63.64% 3.51%
Operating Cash Flow Q/Q Growth
-56.94% 51.40% -24.78% -131.38% 166.60% 28.58% -24.78% -25.31% -1,991.70% -102.64%
Free Cash Flow Firm Q/Q Growth
-868.73% -93.95% -129.78% -96.07% 252.27% -357.04% 293.12% 85.99% 41.33% 19.10%
Invested Capital Q/Q Growth
82.59% 160.42% 170.13% 144.45% -46.44% 41.95% -34.15% -4.46% 24.60% -10.30%
Profitability Metrics
- - - - - - - - - -
Gross Margin
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin
-82.65% -260.54% -286.92% -472.30% -32.03% -50.73% -56.05% -332.62% -60.84% -113.08%
Operating Margin
-24.96% -310.17% -231.61% -341.71% -53.67% -30.88% -57.11% -320.35% -197.09% -140.47%
EBIT Margin
-83.51% -258.22% -281.01% -456.26% -27.72% -49.50% -56.49% -335.70% -67.21% -121.07%
Profit (Net Income) Margin
-87.51% -266.59% -287.71% -463.31% -51.62% -41.02% -48.23% -320.45% -55.72% -120.00%
Tax Burden Percent
103.63% 100.00% 100.00% 100.00% 208.02% 100.00% 100.00% 100.00% 96.67% 103.44%
Interest Burden Percent
101.12% 103.24% 102.38% 101.55% 89.51% 82.87% 85.36% 95.46% 85.76% 95.83%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-29.44% -296.03% -338.34% -540.02% -88.21% -36.81% -59.14% -190.89% -227.58% -433.74%
ROIC Less NNEP Spread (ROIC-NNEP)
-23.31% -294.61% -332.84% -533.72% -87.05% -34.93% -58.54% -187.89% -230.40% -432.76%
Return on Net Nonoperating Assets (RNNOA)
21.02% 265.61% 296.32% 472.79% 77.73% 30.65% 52.23% 157.97% 198.93% 389.32%
Return on Equity (ROE)
-8.42% -30.42% -42.02% -67.23% -10.47% -6.16% -6.91% -32.92% -28.65% -44.42%
Cash Return on Invested Capital (CROIC)
-243.68% -150.64% -183.67% -64.22% -54.01% -131.81% -118.27% -70.04% -59.54% 37.05%
Operating Return on Assets (OROA)
-9.63% -26.79% -48.80% -88.75% -5.35% -8.91% -7.86% -39.62% -15.98% -46.92%
Return on Assets (ROA)
-10.09% -27.66% -49.97% -90.13% -9.95% -7.38% -6.71% -37.82% -13.25% -46.51%
Return on Common Equity (ROCE)
-8.45% -30.48% -42.08% -67.25% -10.47% -6.16% -6.91% -32.92% -28.65% -44.42%
Return on Equity Simple (ROE_SIMPLE)
0.00% -28.61% -32.88% -23.26% 0.00% -17.79% -18.78% -20.41% 0.00% 4.14%
Net Operating Profit after Tax (NOPAT)
-9.22 -39 -39 -38 -19 -13 -18 -43 -30 -27
NOPAT Margin
-17.47% -217.12% -162.12% -239.20% -37.57% -21.62% -39.98% -224.24% -137.96% -98.33%
Net Nonoperating Expense Percent (NNEP)
-6.14% -1.42% -5.49% -6.31% -1.15% -1.88% -0.59% -3.00% 2.82% -0.98%
Return On Investment Capital (ROIC_SIMPLE)
-1.10% -4.40% -5.32% -4.88% -2.25% -1.91% -2.68% -5.76% -4.10% -
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
28.25% 82.98% 74.23% 86.18% 29.97% 21.12% 25.17% 74.64% 59.01% 45.33%
R&D to Revenue
96.71% 327.19% 257.38% 355.52% 123.70% 109.76% 131.93% 345.70% 238.08% 195.15%
Operating Expenses to Revenue
124.96% 410.17% 331.61% 441.71% 153.67% 130.88% 157.11% 420.35% 297.09% 240.47%
Earnings before Interest and Taxes (EBIT)
-44 -46 -67 -73 -14 -29 -26 -64 -15 -33
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-44 -46 -69 -76 -16 -30 -26 -63 -13 -31
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
2.37 1.75 2.12 2.25 1.95 1.83 2.22 2.45 2.14 2.15
Price to Tangible Book Value (P/TBV)
2.44 1.80 2.20 2.33 2.01 1.88 2.28 2.52 2.20 2.20
Price to Revenue (P/Rev)
14.55 13.48 8.30 8.18 7.40 8.41 13.30 17.08 9.48 5.22
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 71.46
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.40%
Enterprise Value to Invested Capital (EV/IC)
12.21 12.76 9.64 15.94 14.10 7.15 14.10 11.31 9.28 11.26
Enterprise Value to Revenue (EV/Rev)
9.17 6.29 4.90 4.86 3.89 4.42 7.87 11.08 5.67 3.06
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 23.83
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 32.50
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 17.56
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 20.10 23.16 13.64 0.00 0.00 0.00 0.00 38.13 8.21
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 36.44
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.24 0.24 0.33 0.31 0.29 0.00 0.00 0.08 0.00 0.00
Long-Term Debt to Equity
0.17 0.18 0.26 0.25 0.24 0.00 0.00 0.08 0.00 0.00
Financial Leverage
-0.90 -0.90 -0.89 -0.89 -0.89 -0.88 -0.89 -0.84 -0.86 -0.90
Leverage Ratio
1.43 1.29 1.32 1.32 1.30 1.16 1.15 1.15 0.95 1.14
Compound Leverage Factor
1.45 1.34 1.35 1.35 1.17 0.96 0.98 1.10 0.81 1.09
Debt to Total Capital
19.53% 19.66% 24.68% 23.58% 22.25% 0.00% 0.00% 7.42% 0.00% 0.00%
Short-Term Debt to Total Capital
5.78% 5.06% 5.34% 4.36% 3.25% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
13.75% 14.61% 19.33% 19.23% 19.00% 0.00% 0.00% 7.42% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
-0.43% -0.33% -0.24% -0.04% 0.04% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
80.90% 80.67% 75.57% 76.46% 77.71% 100.00% 100.00% 92.58% 100.00% 100.00%
Debt to EBITDA
-0.70 -0.77 -0.90 -1.20 -1.40 0.00 0.00 -0.39 0.00 0.00
Net Debt to EBITDA
2.52 2.96 2.39 3.57 4.55 0.00 0.00 4.22 0.00 0.00
Long-Term Debt to EBITDA
-0.49 -0.57 -0.70 -0.98 -1.20 0.00 0.00 -0.39 0.00 0.00
Debt to NOPAT
-1.31 -1.18 -1.56 -1.99 -2.05 0.00 0.00 -0.46 0.00 0.00
Net Debt to NOPAT
4.73 4.51 4.13 5.92 6.63 0.00 0.00 4.95 0.00 0.00
Long-Term Debt to NOPAT
-0.92 -0.88 -1.22 -1.63 -1.75 0.00 0.00 -0.46 0.00 0.00
Altman Z-Score
3.02 2.16 1.99 2.47 2.71 6.76 9.24 8.39 8.33 8.78
Noncontrolling Interest Sharing Ratio
-0.24% -0.21% -0.15% -0.03% 0.02% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
6.61 6.49 7.53 8.09 8.60 10.77 13.30 9.68 10.58 7.42
Quick Ratio
6.39 6.26 7.20 7.85 8.35 10.36 12.80 9.34 10.21 7.17
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-44 5.74 -47 7.48 33 -22 8.52 -4.41 -31 -54
Operating Cash Flow to CapEx
-2,995.01% -2,490.67% -2,278.62% -43,075.00% 1,853.98% -963.31% -991.44% -283.91% -245.14% -8.29%
Free Cash Flow to Firm to Interest Expense
0.00 0.64 -5.05 0.77 0.00 -3,127.86 1,216.87 -630.11 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 -3.52 -7.43 -5.88 0.00 -3,897.29 -5,457.14 -4,373.43 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 -3.66 -7.75 -5.89 0.00 -4,301.86 -6,007.57 -5,913.86 0.00 0.00
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.12 0.10 0.17 0.19 0.19 0.18 0.14 0.12 0.24 0.39
Accounts Receivable Turnover
2.61 2.28 5.03 7.87 6.62 2.91 3.05 1.81 3.45 9.08
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
1.75 1.41 2.13 2.54 2.79 2.44 2.12 2.06 3.77 7.90
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
139.71 159.99 72.63 46.40 55.12 125.48 119.59 201.15 105.77 40.20
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
139.71 159.99 72.63 46.40 55.12 125.48 119.59 201.15 105.77 40.20
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
83 45 71 50 48 90 63 96 101 81
Invested Capital Turnover
1.69 1.36 2.09 2.26 2.35 1.70 1.48 0.85 1.65 4.41
Increase / (Decrease) in Invested Capital
35 -44 8.12 -46 -52 9.11 -27 -38 1.68 27
Enterprise Value (EV)
1,014 580 688 803 679 642 892 1,087 934 909
Market Capitalization
1,608 1,243 1,167 1,353 1,292 1,221 1,508 1,674 1,560 1,551
Book Value per Share
$9.68 $11.46 $8.93 $9.82 $10.87 $11.04 $11.24 $11.39 $12.14 $12.11
Tangible Book Value per Share
$9.42 $11.17 $8.62 $9.51 $10.56 $10.73 $10.93 $11.08 $11.83 $11.80
Total Capital
838 879 728 785 852 669 679 738 727 723
Total Debt
164 173 180 185 189 0.00 0.00 55 0.00 0.00
Total Long-Term Debt
115 128 141 151 162 0.00 0.00 55 0.00 0.00
Net Debt
-591 -660 -477 -549 -614 -579 -616 -587 -627 -642
Capital Expenditures (CapEx)
1.66 1.28 3.03 0.13 0.98 2.83 3.85 11 9.97 14
Debt-free, Cash-free Net Working Capital (DFCFNWC)
41 0.26 24 2.04 -4.33 24 -2.44 -23 -12 -22
Debt-free Net Working Capital (DFNWC)
539 543 532 538 589 518 549 565 611 578
Net Working Capital (NWC)
490 499 493 504 562 518 549 565 611 578
Net Nonoperating Expense (NNE)
37 8.80 30 36 7.16 11 3.76 18 -18 5.92
Net Nonoperating Obligations (NNO)
-591 -660 -477 -549 -614 -579 -616 -587 -627 -642
Total Depreciation and Amortization (D&A)
0.45 -0.41 -1.41 -2.57 -2.20 -0.73 0.20 0.58 1.38 2.18
Debt-free, Cash-free Net Working Capital to Revenue
36.96% 0.28% 16.97% 1.23% -2.48% 16.25% -2.15% -23.56% -7.03% -7.50%
Debt-free Net Working Capital to Revenue
487.47% 588.88% 378.66% 325.31% 337.54% 356.70% 484.09% 576.18% 371.55% 194.61%
Net Working Capital to Revenue
443.62% 540.69% 350.97% 304.63% 321.67% 356.70% 484.09% 576.18% 371.55% 194.61%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
($0.57) ($0.72) ($1.09) ($1.20) ($0.41) ($0.40) ($0.37) ($1.02) ($0.21) ($0.55)
Adjusted Weighted Average Basic Shares Outstanding
65.04M 64.02M 61.68M 61.21M 60.50M 60.62M 59.81M 59.77M 59.65M 59.72M
Adjusted Diluted Earnings per Share
($0.57) ($0.72) ($1.09) ($1.20) ($0.41) ($0.40) ($0.37) ($1.02) ($0.20) ($0.55)
Adjusted Weighted Average Diluted Shares Outstanding
65.04M 64.02M 61.68M 61.21M 60.50M 60.62M 59.81M 59.77M 59.65M 59.72M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
70.46M 69.98M 61.83M 61.66M 61.12M 60.88M 60.61M 60.39M 60.03M 59.92M
Normalized Net Operating Profit after Tax (NOPAT)
-9.22 -39 -39 -38 -19 -13 -18 -43 -30 -27
Normalized NOPAT Margin
-17.47% -217.12% -162.12% -239.20% -37.57% -21.62% -39.98% -224.24% -137.96% -98.33%
Pre Tax Income Margin
-84.45% -266.59% -287.71% -463.31% -24.82% -41.02% -48.23% -320.45% -57.64% -116.02%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.00 -5.09 -7.24 -7.54 0.00 -4,183.57 -3,674.00 -9,093.57 0.00 0.00
NOPAT to Interest Expense
0.00 -4.28 -4.18 -3.95 0.00 -1,827.00 -2,599.70 -6,074.40 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 -5.23 -7.56 -7.56 0.00 -4,588.14 -4,224.43 -10,634.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 -4.42 -4.50 -3.97 0.00 -2,231.57 -3,150.13 -7,614.83 0.00 0.00
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-5.11% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Xencor's Financials

When does Xencor's fiscal year end?

According to the most recent income statement we have on file, Xencor's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Xencor's net income changed over the last 2 years?

Xencor's net income appears to be on an upward trend, with a most recent value of -$236.54 million in 2024, rising from -$55.18 million in 2022. The previous period was -$133.30 million in 2023. Find out what analysts predict for Xencor in the coming months.

What is Xencor's operating income?
Xencor's total operating income in 2024 was -$178.41 million, based on the following breakdown:
  • Total Gross Profit: $110.49 million
  • Total Operating Expenses: $288.90 million
How has Xencor revenue changed over the last 2 years?

Over the last 2 years, Xencor's total revenue changed from $164.58 million in 2022 to $110.49 million in 2024, a change of -32.9%.

How much debt does Xencor have?

Xencor's total liabilities were at $277.92 million at the end of 2024, a 8.3% decrease from 2023, and a 134.0% increase since 2022.

How much cash does Xencor have?

In the past 2 years, Xencor's cash and equivalents has ranged from $40.88 million in 2024 to $53.94 million in 2022, and is currently $40.88 million as of their latest financial filing in 2024.

How has Xencor's book value per share changed over the last 2 years?

Over the last 2 years, Xencor's book value per share changed from 12.14 in 2022 to 9.68 in 2024, a change of -20.2%.



This page (NASDAQ:XNCR) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners